000			01480 a2200445 4500
005			20250513100112.0
264		0	_c19961113
008			199611s 0 0 eng d
022			_a0301-0430
040			_aNLM _beng _cNLM
100	1		_aFriedlander, M A
245	0	0	_aThe advanced glycation endproduct pentosidine and monocyte activation in uremia. _h[electronic resource]
260			_bClinical nephrology _cJun 1996
300			_a379-82 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aArginine _xanalogs & derivatives
650	0	4	_aBiomarkers _xblood
650	0	4	_aBiopterins _xanalogs & derivatives
650	0	4	_aChromatography, High Pressure Liquid
650	0	4	_aCross-Linking Reagents _xmetabolism
650	0	4	_aDisease Progression
650	0	4	_aGlycation End Products, Advanced _xblood
650	0	4	_aHumans
650	0	4	_aKidney Failure, Chronic _xblood
650	0	4	_aLysine _xanalogs & derivatives
650	0	4	_aMonocytes _ximmunology
650	0	4	_aNeopterin
650	0	4	_aPeritoneal Dialysis
650	0	4	_aRadioimmunoassay
650	0	4	_aRenal Dialysis
650	0	4	_aUremia _xblood
700	1		_aWitko-Sarsat, V
700	1		_aNguyen, A T
700	1		_aWu, Y C
700	1		_aLabrunte, M
700	1		_aVerger, C
700	1		_aJungers, P
700	1		_aDescamps-Latscha, B
773	0		_tClinical nephrology _gvol. 45 _gno. 6 _gp. 379-82
999			_c8789650 _d8789650